These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 8427174

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy.
    Bonow RO, Rosing DR, Bacharach SL, Green MV, Kent KM, Lipson LC, Maron BJ, Leon MB, Epstein SE.
    Circulation; 1981 Oct; 64(4):787-96. PubMed ID: 7196813
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Doppler evaluation of left ventricular filling: effect of verapamil on non-obstructive hypertrophic cardiomyopathy.
    Friart A, Stamatakis L, Philippart C.
    Eur Heart J; 1990 Sep; 11(9):839-44. PubMed ID: 2226510
    [Abstract] [Full Text] [Related]

  • 8. Effects of verapamil on left ventricular systolic and diastolic function in patients with hypertrophic cardiomyopathy: pressure-volume analysis with a nonimaging scintillation probe.
    Bonow RO, Ostrow HG, Rosing DR, Cannon RO, Lipson LC, Maron BJ, Kent KM, Bacharach SL, Green MV.
    Circulation; 1983 Nov; 68(5):1062-73. PubMed ID: 6684510
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Acute and chronic effects of verapamil on indices of systolic and diastolic function of the left ventricle in patients with hypertrophic cardiomyopathy].
    La Canna G, Giubbini R, Caobelli A, Pizzocaro C, Soccisi MC, Guerra UP, Arosio G.
    G Ital Cardiol; 1987 Sep; 17(9):744-53. PubMed ID: 3692075
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of diltiazem on left ventricular systolic and diastolic function in hypertrophic cardiomyopathy.
    Betocchi S, Piscione F, Losi M A, Pace L, Boccalatte M, Perrone-Filardi P, Cappelli-Bigazzi, Briguori C, Manganelli F, Ciampi Q, Salvatore M, Chiariello M.
    Am J Cardiol; 1996 Aug 15; 78(4):451-7. PubMed ID: 8752192
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of cibenzoline, a class ia antiarrhythmic agent, on left ventricular diastolic function in hypertrophic cardiomyopathy.
    Kondo I, Mizushige K, Nozaki S, Iwado Y, Masugata H, Kohno M, Matsuo H.
    Cardiovasc Drugs Ther; 2001 Sep 15; 15(5):459-65. PubMed ID: 11855665
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Use of calcium-channel blocking drugs in hypertrophic cardiomyopathy.
    Rosing DR, Idänpään-Heikkilä U, Maron BJ, Bonow RO, Epstein SE.
    Am J Cardiol; 1985 Jan 25; 55(3):185B-195B. PubMed ID: 3881913
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.